Eva Sum

510 total citations
7 papers, 59 citations indexed

About

Eva Sum is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Eva Sum has authored 7 papers receiving a total of 59 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in Eva Sum's work include Advanced Breast Cancer Therapies (3 papers), Cancer Treatment and Pharmacology (3 papers) and HER2/EGFR in Cancer Research (2 papers). Eva Sum is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), Cancer Treatment and Pharmacology (3 papers) and HER2/EGFR in Cancer Research (2 papers). Eva Sum collaborates with scholars based in Germany, United States and Switzerland. Eva Sum's co-authors include Christine Trumpfheller, Moritz Rapp, Pablo Umaña, Pedro Romero, Jackeline F. Romero, Marie‐Catherine Vozenin, Genrich V. Tolstonog, Sara Labiano, Vincent Roh and Christian Simon and has published in prestigious journals such as Clinical Cancer Research, Annals of Oncology and Digestive Diseases and Sciences.

In The Last Decade

Eva Sum

7 papers receiving 59 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Sum Germany	3	34	24	11	9	8	7	59
Ashwini Raghavendra India	3	28 0.8×	25 1.0×	31 2.8×	4 0.4×	9 1.1×	5	67
Anushka De Costa United States	4	55 1.6×	30 1.3×	13 1.2×	16 1.8×	10 1.3×	7	69
Jessica Waninger United States	6	38 1.1×	21 0.9×	19 1.7×	8 0.9×	13 1.6×	12	64
Samuel M. Rubinstein United States	5	42 1.2×	11 0.5×	16 1.5×	6 0.7×	13 1.6×	10	68
Atousa Khiabany United Kingdom	3	16 0.5×	46 1.9×	22 2.0×	9 1.0×	6 0.8×	4	69
Paul Farrington United Kingdom	3	30 0.9×	16 0.7×	27 2.5×	5 0.6×	7 0.9×	4	51
Jaya Thomas United Kingdom	3	23 0.7×	17 0.7×	9 0.8×	6 0.7×	6 0.8×	6	38
Hwoei Fen Soo Hoo Malaysia	3	27 0.8×	8 0.3×	7 0.6×	10 1.1×	14 1.8×	4	37
Shusuke Kawashima Japan	4	32 0.9×	28 1.2×	22 2.0×	4 0.4×	8 1.0×	6	61
Yuemei Wang United States	4	51 1.5×	12 0.5×	11 1.0×	8 0.9×	6 0.8×	13	85

Countries citing papers authored by Eva Sum

Since Specialization

Citations

This map shows the geographic impact of Eva Sum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Sum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Sum more than expected).

Fields of papers citing papers by Eva Sum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Sum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Sum. The network helps show where Eva Sum may publish in the future.

Co-authorship network of co-authors of Eva Sum

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Sum. A scholar is included among the top collaborators of Eva Sum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Sum. Eva Sum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Jacot, William, Yen‐Shen Lu, Sara M. Tolaney, et al.. (2025). 355P Dynamic analysis of liver enzyme elevation in patients (pts) with HR+/HER2− advanced breast cancer (ABC) treated with first-line (1L) ribociclib (RIB). ESMO Open. 10. 104926–104926. 1 indexed citations

2.

Barrios, Carlos H., Nadia Harbeck, Gabriel N. Hortobágyi, et al.. (2024). 113MO NATALEE update: Safety and treatment (tx) duration of ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC). ESMO Open. 9. 103101–103101. 2 indexed citations

3.

Tarantino, Paolo, Joyce O’Shaughnessy, W Janni, et al.. (2024). 245P Characteristics of real-world (RW) NATALEE and monarchE eligible populations: A US electronic health records (EHR) database analysis. Annals of Oncology. 35. S317–S318. 1 indexed citations

4.

Jacot, William, Sara M. Tolaney, Hope S. Rugo, et al.. (2024). 277P Descriptive analysis of hepatic safety for patients (pts) with HR+/HER2− breast cancer (BC) treated with ribociclib (RIB) + endocrine therapy (ET). ESMO Open. 9. 103335–103335. 1 indexed citations

5.

Sum, Eva, Moritz Rapp, Harald Dürr, et al.. (2022). The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation. Journal for ImmunoTherapy of Cancer. 10(3). e003264–e003264. 17 indexed citations

6.

Labiano, Sara, Vincent Roh, Jackeline F. Romero, et al.. (2021). CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors. Clinical Cancer Research. 27(14). 4054–4065. 27 indexed citations

7.

Friedenberg, Frank K., et al.. (2008). Tonic and Phasic Pyloric Activity in Response to CCK-Octapeptide. Digestive Diseases and Sciences. 53(4). 905–911. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact